LEAP-001: Lenvatinib plus Pembrolizumab vs. Chemotherapy as First-Line Therapy for Advanced Endometrial Cancer Last updated on Jun 8, 2026 Previous Anticoagulation and Bleeding Next Publications Update # 83
